Introduction
The amount of drug or cosmetic active ingredient that can be delivered into (dermal delivery) or through (transdermal delivery) the skin depends on the integrity of the skin barrier, the physicochemical properties of the permeant, the physicochemical characteristics of the vehicle in which the permeant is applied to the skin and the dosing conditions [1] . The outermost layer of the skin, the stratum corneum, is recognized to be the major barrier to the transport of molecules across healthy skin. One way to enhance the dermal and transdermal delivery is to reduce the resistance of the stratum corneum to penetration by including penetration modifiers. Two main mechanisms of penetration enhancement can be distinguished. Firstly, the penetration modifier enters the skin, increases the permeant's solubility in the skin (solubility modifier) and therefore increases the partition coefficient of the active ingredient between skin and vehicle. Secondly, the penetration enhancer diffuses into the skin and interrupts the intercellular lipid packing and hence
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Abstract
In this study the effect of 2 penetration modifiers, dimethyl isosorbide (DMI) and diethylene glycol monoethyl ether (DGME) on the skin delivery of hydroquinone (HQ), salicylic acid (SA) and octadecenedioic acid (DIOIC) was investigated. Ten percent DMI and DGME were separately formulated into oil-in-water emulsions containing 1.8% HQ, SA and DIOIC, respectively. Skin delivery and the flux across split-thickness human skin of the active ingredients were determined using Franz diffusion cells. An emulsion with 10% water incorporated instead of the water-soluble penetration modifiers served as a control. The study showed that neither 10% DMI nor 10% DGME significantly enhanced the skin permeation of the various lipophilic active ingredients or the uptake into the skin. It was hypothesized that the addition of the penetration modifiers to the emulsions not only enhanced the solubility of the various active ingredients in the skin but also in the formulation, resulting in a reduced thermodynamic activity and hence a weaker driving force for penetration. Therefore, the effect of DMI and DGME on the solubil-increases the diffusivity (diffusion coefficient) of the permeant in the skin. Azone (laurocapram) and terpenes are examples of molecules that disrupt the ordered lipid bilayer structure of the stratum corneum and hence increase the intercellular lipid fluidity, resulting in enhanced diffusivity of the permeant [2] . Care has to be taken in using this kind of penetration enhancer because of their skin irritancy potential [3] .
The solubility penetration modifiers that worked via increasing the solubility of the drug or cosmetic ingredient in the skin were used in this study. Diethylene glycol monoethyl ether (Transcutol , DGME) is an excellent solubilizing, non-toxic as well as skin biocompatible agent [4] which penetrates skin [5] . It was found that DGME did not influence the diffusivity of the permeant, e.g. no changes in the differential scanning calorimetry thermograms of DGME-treated skin were detected [6] . Furthermore, studies showed that DGME acted mainly by enhancing the permeant's solubility in the skin [7, 8] . DGME has been extensively investigated as a penetration modifier and different results were found. In the presence of DGME the skin retention of dexamethasone and hydrocortisone was enhanced while the permeability and therefore the transdermal delivery were significantly decreased, indicating the development of an intracutaneous depot for these 2 drugs [9] . Similar results were acquired by Godwin et al. [4] and Mutalik and Udupa [10] , who found an increase in the dermal delivery of cinnamate, oxybenzone, glibenglamide and glipizide without an enhanced transdermal delivery. Additionally, it was observed that the effect of DGME was concentration dependent as the skin accumulation improved with increasing concentration of DGME in the vehicle [4, 9] . Other studies obtained an increase in permeability and transdermal delivery, e.g. of metoprolol, griseofulvin, as well as lorazepam and clonazepam [8, 11, 12] , or no permeability enhancement, e.g. of heparin [13] .
In this study another possible solvent-type penetration enhancer, dimethyl isosorbide (Arlasolve DMI, DMI) was investigated and compared with DGME. DMI is a very good solvent for non-polar drugs especially in a mixed system with water [14] and it was found that it also could penetrate the skin [15, 16] . Differential scanning calorimetry analysis revealed only a slight change in the phase transition temperature of DMI-treated mouse skin [16] , indicating no significant interruption of intercellular lipid packing and therefore no potential of DMI to increase the diffusivity of the permeants. A study from Twist and Zatz [17] showed that the flux of theophylline and methylparaben from the DMI vehicle was reduced compared with the water vehicle. However, no data of skin retention were attained. Recently, Rossi et al. [18] discovered that the addition of DMI to an emulsion increased the dermal delivery of the hydrophilic penetrant propagermanium, while no enhanced permeation through the skin was obtained.
Three different active ingredients, hydroquinone (HQ), salicylic acid (SA) and octadecenedioic acid (DIOIC), with different lipophilicities were used in this study to investigate the effect of DMI (in comparison with DGME) as a solubility modifier on the dermal and transdermal delivery. HQ and DIOIC are known depigmentation agents used in skin toning products and in pharmaceutical formulations for the treatment of melasma. Both inhibit the synthesis of melanin; however, the mechanism of action is different for HQ and DIOIC. HQ functions by directly inhibiting the existing tyrosinase enzyme, whereas DIOIC reduces the formation of new tyrosinase enzyme by binding to the ␥ -isoform of the peroxisome proliferator-activated receptor, yielding a reduced expression of tyrosinase mRNA [19] . SA is a wellestablished keratolytic utilized, among other indications, in the treatment of acne and psoriasis. The site of action for all 3 active ingredients is the epidermis. Therefore, there is considerable interest in the increase in skin accumulation (more specifically epidermis), while the transdermal delivery should be decreased as to minimize the systemic availability of HQ, SA and DIOIC. Because DGME and DMI have shown to be capable of enhancing dermal delivery without enhancing transdermal delivery, both penetration modifiers were employed in this study to assess the effect on the dermal and transdermal delivery of HQ, SA and DIOIC from an oil-in-water (o/w) emulsion.
Materials and Methods

Materials
HQ from Fluka (Buchs, Switzerland), SA from Sigma Aldrich (Dorset, UK) and Arlatone TM Dioic DCA from Uniqema (Gouda, The Netherlands) were used as test substances. DMI was kindly provided by Uniqema (Gouda, The Netherlands). DGME (Transcutol) was obtained from Gattefossé (Saint Priest, France). HQ-d 6 , 2-hydroxybenzoic acid-d 6 and 1,18-octadecanedioic acid were purchased from Dr. Ehrenstorfer (Augsburg, Germany) and were used as internal standards for gas chromatography with mass spectrometric detection (GC-MS). Methanol (Hypersolv TM , HPLC grade) and absolute ethanol (Chromasolv TM ) were obtained from BDH (Dorset, UK) and Sigma Aldrich (Johannesburg, South Africa), respectively. N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) and trimethylchlorosilane (TMCS) were purchased from Supelco (Bellefonte, Pa., USA). Dried pyridine (max. 0.0075% H 2 O) was obtained from Riedel de Haën (Seelze, Germany). Disodium dihydrogen ethylenediaminetetraacetate (disodium EDTA) was obtained from BASF (Cheshire, UK) and sodium disulphite was purchased from Merck (Darmstadt, Germany). Deionized water from a Millipore Milli-Q purification system was employed. The test formulations (o/w emulsions) were prepared at Uniqema (Wilton, UK) and 10% water, DMI or DGME was added afterwards, prior to the diffusion experiments. The composition of the 9 final test formulations is described in table 1 . The structural formulae, molecular weights and octanol water partition coefficients (logP) of HQ, SA and DIOIC as well as of the permeation modifiers DMI and DGME are presented in table 2 . HQ, SA and DIOIC were chosen in this study as they covered a range of lipophilicities from slightly (HQ) to very lipophilic (DIOIC) as indicated by the octanol water partition coefficients.
Statistical Design of the Permeation Experiments
A randomized complete block design was used to assess the effects of skin donor variability as well as formulation on dermal and transdermal delivery. Three different skin donors were used per formulation and each formulation was applied in duplicate on each skin donor, giving a total of 6 replicates per experiment.
Solubility Studies
The solubility of HQ, SA and DIOIC in water, DMI and DGME, respectively, was assessed by stirring excess amounts of each compound in the relevant pure solvent for 48 h. The solubility was determined at 20 ° C and each experiment was conducted in duplicate. After saturation had occurred, the samples were withdrawn, filtered and analyzed by GC-MS.
Preparation of Human Skin Membranes
The project 'In vitro transdermal delivery of drugs through human skin' was approved by the ethics committee of the NorthWest University (Potchefstroom, South Africa) and skin was obtained with informed consent of the donors.
Fresh white, female abdominal skin was obtained from cosmetic surgery and prepared within 24 h after surgery. The skin was rinsed with deionized water and dried with a paper tissue. The surface of the skin was once wiped with an ethanol-moistened cotton swab to remove possible fat residual from the subcutaneous fat layer and surface sebaceous lipids. A skin layer of a thickness of 400 m including the stratum corneum, viable epidermis and upper dermis with a width of 2.5 cm was prepared using an electric dermatome (Zimmer, Inc., Warsaw, Ind., USA). The skin was placed with the dermal side facing down on filter paper and stored in aluminium foil at -20 ° C until use. The time of storage did not exceed 6 months. One hour prior to the diffusion experiments the skin was thawed at room temperature and cut into circular pieces (15 mm in diameter).
Permeation Experiments
Franz-type diffusion cells with an exposed skin area of 1.13 cm 2 and a receptor volume of approximately 2 ml were employed. The experiments were conducted in a water bath maintained at a temperature of 37 8 1 ° C. Preceding permeation experiments, skin integrity was assessed by measuring the electrical resistance across the skin [20] . The prepared skin pieces were placed with the epidermal side facing up between the donor and receptor compartment. The donor and receptor chambers were filled with 0.9% aqueous sodium chloride, degassed in an ultrasonic water bath for 15 min, and the Franz diffusion cells were placed in a preheated water bath. After an equilibration period of 30 min the electrical resistance was measured using a Tinsley LCR Databridge Model 6401 (Tinsley Precision Instruments, Croydon, UK). The reading was determined at 1 kHz with a maximum voltage of 300 mV root mean square in the parallel equivalent circuit mode using an alternating current [20] . Cells with a resistance lower than 10 k⍀ were rejected and for comparison studies, the cells with similar resistance values within 1 skin donor were chosen for diffusion studies. After the resistance measurements the aqueous sodium chloride was removed. The receptor chamber was filled with pre-heated receptor solution consisting of water/ ethanol (1: 1, v/v). Electrical resistance measurements indicated that the skin barrier integrity was not affected by 50% ethanol in the receptor fluid after 24-hour permeation studies (see 'Discussion'). The high reduction potential of HQ necessitated stabilization of the receptor medium with 0.02% (w/v) disodium EDTA (for chelating metal ions) and 0.015% (w/v) sodium disulphite (as anti-oxidant). Prior to filling the receptor chamber, the receptor fluid was degassed in an ultrasonic bath for 15 min to prevent air pockets underneath the skin membrane. The receptor fluid was stirred with a magnetic stirrer at 500 rpm. The surface of the skin was dried with a dry cotton swab. The system was equilibrated in the water bath for another 30 min followed by the application of the formulations. Twenty-five microlitres of the emulsions were applied with a 25-l Microman positive displacement pipette (Gilson, Inc., Middleton, Wisc., USA) and spread evenly on the skin surface area with the tip of the pipette. The applied amount of formulation was higher than what is used in practice to allow the determination of flux data. The residue remaining on the tip of the pipette was analyzed and the exact applied amount of active ingredient could be calculated for each cell. The donor compartment was covered with a cap. At specified time intervals the entire receptor fluid was withdrawn and replaced with fresh pre-heated receptor media. The duration of the study was 24 h for DIOIC and 8 h for HQ and SA. The shorter experimental time for HQ and SA was chosen because of their much faster permeation.
Sample Preparation
At the completion of the diffusion study, the receptor chamber was retained and rinsed twice with fresh receptor fluid. These solutions were subsequently added to the last receptor sample. After rinsing the receptor chamber, the donor residual left on the surface of the skin after the conclusion of the permeation experiments was removed with methanol-moistened cotton swabs. The skin was removed from the cells and placed with the dermal side facing down on a microscope slide. The stratum corneum was partially removed by tape stripping the skin membrane 15 times using 3M Scotch Magic TM tape (tape strip sample). Tests performed prior to the experiments showed that tape stripping more than 15 times did not increase the amount of permeant in the tape strip samples. The remainder of the skin (rest skin sample) was cut into smaller pieces to increase the surface area for extraction. Methanol (SA, DIOIC) and aqueous stabilization solution of 0.02% (w/v) disodium EDTA and 0.015% (w/v) sodium disulphite in deionized water (HQ), respectively, was added for extraction. A specified amount of respective internal standard was immediately added to all the samples and vortex mixed. The internal standards were deuterium labelled HQ-d 6 (HQ), SA-d 6 (SA) and 1,18-octadecanedioic acid (DIOIC), respectively. The samples were extracted over a period of at least 24 h and stored at 4 ° C. The DIOIC samples were refrigerated at -20 ° C until analysis. A longer storage period did not have an effect on stability (tests were performed prior to the experiments). Preceding analysis, the samples were brought to room temperature for equilibration, vortex mixed for 1 min and diluted with the appropriate extraction fluid as required. A specified volume of the sample was pipetted into microinserts of auto-sampler vials and carefully dried under a stream of nitrogen. The samples were then derivatized with BSTFA, TMCS and pyridine (HQ and SA: 25 l BSTFA with 1% TMCS + 25 l pyridine, 30 min at 40 ° C; DIOIC: 25 l BSTFA with 15% TMCS + 25 l pyridine, 60 min at 75 ° C).
Analytical Methods
The TMS derivatives were analyzed using an Agilent 6890 Plus GC equipped with an Agilent 5973 Mass Selective (MS) Detector in electron impact mode (70 eV). Aliquots of 1 l of each sample 
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-0.62 logP (octanol/water) were calculated using ChemSketch 10.0 + ACD/logP Software (Advanced Chemistry Development, Inc., Toronto, Canada).
were injected and an Agilent DB-5 column (30 m length, 250 m width and 0.25 m film thickness) was used for the analysis of all 3 compounds. The analytical studies of HQ and SA were performed as described previously [21] . The GC parameters for the analysis of DIOIC were as follows. The injector temperature was maintained at 270 ° C and operated in the splitless mode at 0.8 bar, with a purge flow rate of 21.3 ml min -1 after 1.00 min. Ultra-high purity helium was utilized as the carrier gas and the column flow was maintained constant at 1.2 ml min -1 . The initial oven temperature was set at 80 ° C with a 2.0-min hold period and was then ramped to 265 ° C at 20 ° C min -1 and finally ramped from 265 ° C to 300 ° C at a rate of 30 ° C min -1 . The oven was maintained at 300 ° C for 2.0 min for a total run time of 32.42 min. The transfer line was set at 280 ° C, the source temperature at 230 ° C and the quadrupole at 150 ° C. The MS was operated in the selected ion monitoring mode. Ions monitored for the derivatized DIOIC and the respective internal standard were m/z 441 and 443, respectively, measured with a dwell time of 100 ms. The retention time was 24.3 min for DIOIC and 24.7 min for the internal standard. Quantitation was performed based on the ratio of the peak area of the active ingredient to the peak area of the internal standard.
Data and Statistical Analysis
The cumulative amount permeated was plotted versus time (permeation plots) and applied to a curve-fitting procedure described by Díez-Sales et al. [22] . Equation 1 [23] was used to fit the data. 
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where Q(t) is the amount of active ingredient permeating the skin within time t . K is the partition coefficient of the permeant between skin and vehicle, h represents the diffusional path length, D is the diffusion coefficient of the permeant in the skin and C V is the actual concentration of the permeant in the donor vehicle.
As t approaches infinity, the exponential term becomes negligible and equation 1 can be simplified to:
K and D are unknown and therefore the products K ! h and D/h 2 were replaced by ␣ and ␤ , which were determined by fitting equation 2 to the experimental obtained permeation plots using a computerized non-linear least square method (EasyPlot, Spiral Software, Norwich, Vt., USA). The permeability coefficient (k p ) and flux (J) values were calculated using equation 3 and 4, respectively.
Two-way analysis of variance (ANOVA) was performed with Statistica (StatSoft Inc., Tulsa, Okla., USA) using the formulation as a fixed effect and the skin donor as a random effect. The Bonferroni test was employed to compare the various formulations with each other and data with p ! 0.05 were considered statistically significant.
Results
Solubility Studies
The saturated solubility of each compound in water, DMI and DGME, respectively, was determined and the data are shown in table 3 . The HQ solubility was 5 times higher in DMI and DGME compared with its water solubility. SA was slightly water soluble, but the solubility was increased by a factor of approximately 150 in DMI and DGME. DIOIC, practically insoluble in water, showed a much higher solubility in DMI and DGME (more than 1,000,000-fold higher). Comparing the data ( table 3 ), the solubilities of the various compounds were of a similar magnitude in DMI and DGME. However, the solubility was higher in DMI and DGME, compared with water, and the increase in solubility (in DMI and DGME) was higher the more lipophilic the compound. The solubility value of SA in DMI was slightly higher than a previously reported result of 288 8 10 mg/ml at 25 ° C [24] .
Permeation Study
The total recovery of each penetrant at the end of the permeation study was calculated and was effectively in the range of 100-105% for HQ, 95-100% for SA and 88-93% for DIOIC. According to Diembeck et al. [25] , the total recovery of the compound is recommended to be 100 8 15%. The recovery values for HQ and SA in this study are well within this recommended interval. The recoveries of DIOIC were slightly lower, however still acceptable, and the loss of DIOIC might have occurred during removing the residual donor phase after the permeation studies. These recovery values showed the reliability of the permeation data as all the applied amount of compounds could be recovered and no major loss occurred during experiments, extraction, sample handling and analytical detection.
The results of the permeation experiments are presented in figures 1 (HQ), 2 (SA) and 3 (DIOIC) and are expressed as total amount delivered over the duration of the skin penetration experiment as least square means (formulation effect, subtracting the variation contributed by the various skin donors as ANOVA revealed an effect of skin donor on all dependent variables) 8 95% confidence interval (CI). Prior to ANOVA the experimental data were evaluated for normal distribution (ShapiroWilk W test with p 1 0.05) and homogeneity (Bartlett and Levene's test). If required, a logarithmic transformation of the dependent variables was performed in order to obtain normal distribution as well as homogenous variability with subsequent analysis of the log-transformed data. This transformation confirmed that the permeation data here also followed a log-normal distribution as had been previously reported [26] . It can be seen from figures 1-3 that for each compound the 3 tested formulations did not show significant differences in skin retention as well as skin permeation. Statistically significant differences were only observed for the tape strip samples of HQ, where the formulation with 10% DMI and DGME had a lower amount of HQ compared with the control formulation (10% water). Though these differences were statistically significant, they were minor and could be seen as practically not relevant. Because of analytical interference of the adhesive tape used in the DIOIC tape strip samples, these could not be analyzed. Therefore, tape stripping was not conducted after the permeation study and only the amount of DIOIC in the total skin samples was assessed ( fig. 3 ) .
The permeation profiles of HQ and DIOIC were applied to a non-linear curve-fitting procedure [22] to separate the effect of the penetration modifiers on diffusion coefficient and partition coefficient. A pre-study yielded sigmoidal permeation curves of SA, indicating depletion in the donor phase. Therefore, the non-linear curve-fitting procedure was not used for the SA data. The obtained ␣ , ␤ , k p and flux values for HQ and DIOIC are shown in table 4 . Assuming that the diffusional path length was equal for each skin piece, ␣ provided information about changes in the partition coefficient (K) and ␤ revealed Skin permeation data of HQ ( g = 10% water, k = 10% DMI, i = 10% DGME) expressed as total amount delivered over 8 h of skin penetration experiment as least square means (formulation effect) 8 95% confidence interval (CI) obtained after 2-way ANOVA. Fig. 2 . Skin permeation data of SA ( g = 10% water, k = 10% DMI, i = 10% DGME) expressed as total amount delivered over 8 h of skin penetration experiment as least square means (formulation effect) 8 95% confidence interval (CI) obtained after 2-way ANOVA. Fig. 3 . Skin permeation data of DIOIC ( g = 10% water, k = 10% DMI, i = 10% DGME) expressed as total amount delivered over 24 h of skin penetration experiment as least square means (formulation effect) 8 95% confidence interval (CI) obtained after 2-way ANOVA. DIOIC tape strip samples could not be analyzed because of analytical interference; and therefore, tape stripping was not performed and only the amount in the total skin was assessed.
changes in the diffusion coefficient (D) . As expected for DMI and DGME, they slightly increased the skin partitioning ( ϳ ␣ ) of HQ and DIOIC, though in the case of HQ, the differences were not statistically significant. In contrast, the diffusion coefficients ( ϳ ␤ ) of HQ and DIOIC were slightly decreased, and the reduction in ␤ was statistically significant. Nevertheless, the data of ␣ and ␤ should be used judiciously in interpreting the results as the experiments did not produce a sufficient number of data points in the non-steady-state region of the permeation curves to obtain reliable ␤ values [3] . No significant differences were obtained in permeability coefficient and flux data of DIOIC when applied with the penetration modifiers. However, a slightly reduced permeability coefficient (statistically significant for DMI and DGME) and flux (statistically significant for DGME) of HQ was obtained with the formulations containing penetration modifiers.
Discussion
Fifty percent ethanol was used in the receptor fluid to ensure sink conditions for the more lipophilic compounds (DIOIC and SA). The use of ethanol in such a high concentration may be detrimental to the skin barrier properties as ethanol could extract skin lipids [27] . Therefore, prior to the permeation experiments a test was performed to monitor the changes in electrical resistance during the time of permeation studies. The experimental setup was the same as described for the permeation studies except that no emulsion was applied. The electrical resistance was measured at time 0 (before adding the 50% ethanol receptor fluid) and after 24 h of permeation studies. The resistance did not change significantly and it could be concluded that the skin barrier integrity was maintained during 24 h permeation study using 50% ethanol in the receptor fluid. It is also emphasized that the data should not be used to mimic in vivo situations and the experimental setup was employed simply to compare different formulations with each other. Another important fact to mention is that the composition of receptor and donor phase was very different from what might have resulted in a concentration gradient of ethanol across the skin and therefore backdiffusion of ethanol into the donor phase. As this was assumed to take place to the same extent for each experiment, the relative differences between various formulations should be unaffected.
In summary, neither 10% DMI nor 10% DGME in an o/w emulsion resulted in permeation enhancement or increased skin retention of the 3 different compounds ( fig. 1-3 ) after application of a semi-finite dose of the o/w Table 4 . Data of ␣, ␤, permeability coefficient (k p ) and flux (J) after applying a non-linear curve fitting procedure to the permeation profiles of HQ and DIOIC presented as least square means (LSM, formulation effect) 8 95% CI emulsion. An explanation for these results might be the change in driving force for diffusion of the active ingredients because of the addition of the penetration modifiers. The thermodynamic activity of the active ingredient in the donor vehicle determines its driving force for diffusion across the skin. As seen from the solubility results ( table 3 ) , the solubility of all active ingredients was significantly higher in pure DMI and DGME compared with water. Therefore, it was deduced that by the addition of 10% DMI or DGME, the solubility of the active ingredients in the formulations containing a permeation modifier was enhanced to some extent compared with the control formulation (with 10% water). This increase in solubility would result in a reduced thermodynamic activity of the active ingredient and consequently in a smaller driving force for diffusion and therefore a reduced penetration. However, as both DGME and DMI are known to penetrate the skin [5, 15] , this will also increase the solubility of HQ and DIOIC in the stratum corneum, which will enhance skin penetration.
Whether skin penetration is enhanced or reduced, depends on which solubility is most increased. If the solubility in the formulation is more increased than that in the stratum corneum, skin penetration will be reduced. On the other hand, if the solubility of the penetrants in the stratum corneum is more increased than that in the formulation, then skin penetration will be enhanced. The fact that ␣ (a measure for K, the partition coefficient, which is defined as the ratio between the solubility of the penetrant in the stratum corneum and the formulation) was not significantly altered for HQ when either DGME or DMI was added to the formulation means that the 2 effects levelled each other out. The increase in ␣ for DIOIC with DGME and DMI, however, was counteracted by the reduced ␤ , leading to no increase in flux and therefore dermal and transdermal delivery (see fig. 3 ).
It also has to be mentioned that though the experiments were performed under occluded conditions, the appearance of the formulations changed during the application period. In general, after the application of an emulsion onto the skin, water and other volatile components evaporate and therefore, the composition and properties of the emulsion could change during the permeation experiments. In addition, the actual effect of the vehicle on dermal and transdermal delivery is determined by the residual formulation after completion of evaporation [28] . However, to this day, no full understanding exists of the transformation of the vehicle after the application onto the skin [29] .
Conclusion
Neither the addition of 10% DMI nor 10% DGME to an o/w emulsion increased the skin accumulation or the transdermal delivery of HQ, SA and DIOIC. It was hypothesized that the addition of the penetration modifiers to the emulsion not only enhanced the solubility of the various active ingredients in the skin (that would result in enhanced partitioning and penetration) but also in the formulation and therefore decreased the driving force for penetration. To obtain an increase in dermal delivery, the solubility of the active ingredient in the formulation has to be adjusted to compensate for the increase in solubility due to the addition of the penetration modifiers and to achieve a maximum thermodynamic activity.
However, further investigations are necessary to confirm this hypothesis. Permeation experiments with modified emulsions containing the penetration modifiers and adjusted for solubility will give insight into the influence of DMI and DGME on the skin permeation of the various active ingredients. Moreover, it would also be of importance to monitor the permeation of drug and penetration modifier simultaneously as well as the changes in the composition and structure of the emulsion after application onto the skin to gain more knowledge about the mechanism of DMI and DGME.
